Microvessel Density as a Prognostic Factor in Women with Breast Cancer: A Systematic Review of the Literature and Meta-Analysis

Cancer Research

Volumn 64, Issue 9, 2004, Pages 2941-2955

  Uzzan, Bernard ^a,b   Nicolas, Patrick ^a,b   Cucherat, Michel ^c   Perret, Gérard Yves ^a,b  

^a AVICENNE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN;

ANGIOGENESIS; ANTIGEN EXPRESSION; BREAST CANCER; CANCER SURVIVAL; CAPILLARY DENSITY; CLINICAL TRIAL; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; META ANALYSIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VASCULARIZATION;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD38; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FACTOR VIII; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; SURVIVAL RATE;

EID: 2342514123     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1957     Document Type: Review

References (114)

1. Bast RC Jr, Ravdin P, Hayes DF, et al. American Society of Clinical Oncology Tumour Markers Expert Panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the american society of clinical oncology. J Clin Oncol 2001;19:1865-78.
2. Hayes DF, Isaacs C, Stearns V. Prognostic factors in breast cancer: current and new predictors of metastasis. J. Mamm. Gland Biol Neo 2001;6:375-92.
3. Van De Vijver MJ, He YD, Van 'T Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl. J Med 2002;347:1999-2009.
4. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
5. Magennis DP. Angiogenesis. a new marker for breast cancer. Br J Biomed Science 1998;55:214-20.
6. McGuire WL, Clark GM. Current concepts: prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 1992;236:1756-61.
7. Wolff AC, Abeloff MD. Adjuvant chemotherapy for postmenopausal lymph node-negative breast cancer: it ain't necessarily so. J. Natl. Cancer Inst 2002;94:1041-3.
8. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
9. Chalkley HW. Method for the quantitative morphologic analysis of tissues. J. Natl. Cancer Inst 1943;4:47-53.
10. Gasparini G. Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol Hematol 2001;37:97-114.
11. Meert AP, Paesmans M, Martin B, et al. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2002;87:694-701.
12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. J Am Med Assoc 2000;283:2008-12.
13. Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol 1995;8:745-52.
14. Lipponen P, Ji H, Aaltomaa S, Syrjanen K. Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis. J Cancer Res Clin Oncol 1994;120:645-50.
15. Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JRT. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1992;1:223-9.
16. Leek RD. The prognostic role of angiogenesis in breast cancer. Anticancer Res 2001;21:4325-32.
17. Weidner N. Angiogenesis as a predictor of clinical outcome in cancer patients. Hum Pathol 2000;31:403-5.
18. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998;184:119-22.
19. Simpson JF, Battifora H. Angiogenesis as a prognostic factor in breast cancer: can we count on it? Appl Immunochem 1995;3:73-4.
20. Altman DG. Systematic reviews of evaluations of prognostic variables. Br Med J 2001;323:224-8.
21. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995;36:193-204.
22. Gasparini G, Toi M, Verderio P, et al. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients. Int J Oncol 1998;12:1117-25.
23. Guidi AJ, Berry DA, Broadwater G, et al. Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a cancer and leukemia group B correlative science study from protocols 8541/8869. J Clin Oncol 2002;20:732-42.
24. Guidi AJ, Berry DA, Broadwater G, et al. Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 2000;89:69-73.
25. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C. Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 2000;82:339-47.
26. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 2000;6:139-46.
27. Medri L, Nanni O, Volpi A, et al. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer 2000;89:74-80.
28. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34.
29. Cucherat M, Boissel JP, Leizorovicz A, Haugh M. EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 1997;53:187-90.
30. Gunel N, Akcali Z, Coskun U, Akyol G, Yamac D, Yenidunya S. Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. Pathol Res Pract 2002;198:7-12.
31. Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M. Blood vessel invasion as a predictor of long-term survival for japanese patients with breast cancer. Breast Cancer Res Treat 2002;73:1-12.
32. Tynninen O, Sjostrom J, Von Boguslawski K, Bengtsson NO, et al. Tumour microvessel density as predictor of chemotherapy response in breast cancer patients. Br J Cancer 2002;86:1905-8.
33. Kato T, Kameoka S, Kimura T, et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 2001;70:65-74.
34. Kato T, Kameoka S, Kimura T, Nishikawa T, Kasajima T. Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer. Breast Cancer Res. Treat 2001;65:203-15.
35. Lee JS, Kim HS, Jung JJ, Kim YB, Park CS, Lee MC. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior. Analyt Quant Cytol Histol 2001;23:161-8.
36. Ryska A, Hovorkova E, Skrabkova Z. Angiogenesis in breast carcinoma. Immunohistochemical study of 142 cases. Cesk Patol 2001;37:91-8.
37. Vincent-Salomon A, Carton M, Zafrani B, et al. Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases. Cancer 2001;92:249-56.
38. Fridman V, Humblet C, Bonjean K, Boniver J. Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch 2000;437:611-7.
39. Kato T, Kimura T, Miyakawa R, et al. Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer. Br J Cancer, 2000;82:404-11.
40. Takei H, Iino Y, Horiguchi J, et al. Highest microvessel conut as a long-term prognostic factor in Japanese breast cancer patients. Cancer Lett 2000;156:109-16.
41. Tas F, Yavuz E, Aydiner A, et al. Angiogenesis and p53 protein expression in breast cancer. Am J Clin Oncol 2000;23:546-53.
42. De Placido S, Carlomagno C, Ciardello F, et al. Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up. Clin Cancer Res 1999;5:2854-9.
43. Gerson R, Serrano A, Villalobos A, Sanches-Forgach E. Angiogenesis in breast cancer. Proc Am Soc Clin Oncol 1999;18:629a, 2433A.
44. Jitsuiki Y, Hasebe T, Tsuda H, et al. Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod Pathol 1999;12:492-8.
45. Kato T, Kimura T, Ishii N, et al. The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer. Breast Cancer Res Treat 1999;53:19-31.
46. Kumar S, Ghellal A, Li C, et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999;59:856-61.
47. Nakamura G, Arita S, Tanaka K, Hioki K, Tsubura A, Shikata N. Correlation between microvessel density and tumor cell proliferation with clinical factors in breast carcinomas. Oncol Rep 1999;6:1023-7.
48. Tynninen O, Von Boguslawski K, Aronen HJ, Paavonen T. Prognostic value of vascular density and cell proliferation in breast cancer patients. Pathol Res Pract 1999;195:31-7.
49. Viens P, Jacquemier J, Bardou VJ, et al. Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy. Breast Cancer Res Treat 1999;54:205-2.
50. Acenero MJ, Gallego MG, Ballesteros PA, Gonzalez JF. Vascular density as a prognostic indicator for invasive ductal breast carcinoma. Virchows Arch 1998;432:113-7.
51. Acenero MJ, Gonzalez JF, Gallego MG, Ballesteros PA. Vascular enumeration as a significant prognosticator for invasive breast carcinoma. J Clin Oncol 1998;16:1684-8.
52. Chu JS, Huang CS, Chang KJ. The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas. Cancer Lett 1998;134:7-14.
53. Eppenberger U, Kueng W, Schlaeppi JM, Roesel JL, et al. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 1998;16:3129-36.
54. Gasparini G, Brooks PC, Biganzoli E, et al. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 1998;4:2625-34.
55. Heimann R, Ferguson D, Gray S, Hellman S. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat 1998;52:147-58.
56. Jacquemier JD, Penault-Llorca FM, Bertucci F, et al. Angiogenesis as aprognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol 1998;184:130-5.
57. Lampe B, Hantschmann P, Dimpfl T. Prognostic relevance of immunohistology, tumor size and vascular space involvement in axillary node negative breast cancer. Arch. Gynecol Obstet 1998;261:139-46.
58. Mayers MM, Seshadri R, Raymond W, McCaul K, Horsfall DJ. Tumor microvascularity has no independent prognostic significance for breast cancer. Pathology 1998;30:105-10.
59. Narita M, Nakao K, Ogino N, Nakahara M, Onishi A, Tsujimoto M. Independent prognostic factors in breast cancer patients. Am J Surg 1998;175:73-5.
60. Charpin C, Garcia S, Bouvier C, et al. CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas. Correlation with patient follow-up. Am J Clin Pathol 1997;107:534-41.
61. Karelia NH, Patel DD, Balar DB, et al. Prognostic significance of tumor angiogenesis in advanced breast carcinoma: an Indian experience. Neoplasma 1997;44:163-6.
62. Lee AKC, Loda M, Mackarem G, et al. Lymph node negative invasive breast carcinoma 1 centimeter or less in size. Clinicopathological features and outcome. Cancer 1997;79:761-71.
63. Marinho A, Soares R, Ferro J, Lacerda M, Schmitt FC. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol Res Pract 1997;193:267-73.
64. Martin L, Green B, Renshaw C, et al. Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 1997;76:1046-54.
65. Paulsen T, Aas T, Borresen A, Varhaug JE, Lonning PE, Akslen LA. Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. Int J Cancer 1997;74:138-40.
66. Sterns EE, Sen Gupta S, Zee B. Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival. Breast Cancer Res Treat 1997;42:113-20.
67. Aranda FI, Laforga JB. Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases. Path Res Pract 1996;192:124-9.
68. Gasparini G, Fox SB, Verderio P, et al. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. Clin Cancer Res 1996;2:1191-8.
69. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst 1996;88:1764-9.
70. Karaiossifidi H, Kouri E, Arvaniti H, Sfikas S, Vasilaros S. Tumor angiogenesis in node-negative breast cancer: relationship with relapse free survival. Anticancer Res 1996;16:4001-2.
71. Kohlberger PD, Obermair A, Sliutz G, et al. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol 1996;105:705-10.
72. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9.
73. Morphopoulos G, Pearson M, Ryder WDJ, Howell A, Harris M. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 1996;180:44-9.
74. Simpson JF, Ahn C, Battifora H, Esteban JM. Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 1996;77:2077-85.
75. Axelsson K, Ljung BM, Moore DH, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:997-1008.
76. Barbareschi M, Weidner N, Gasparini G, et al. Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs a computer-aided image analysis system. Appl Immunohistochem 1995;3:75-84.
77. Bevilacqua P, Barbareschi M, Verderio P, et al. Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma. Results of a multiparametric study. Breast Cancer Res Treat 1995;36:205-17.
78. Charpin C, Devictor B, Bergeret D, et al. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Am J Clin Pathol 1995;103:443-8.
79. Costello P, McCann A, Carney DN, Dervan PA. Prognostic significance of microvessel density in lymph node negative breast carcinoma Hum Pathol 1995;26:1181-4.
80. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995;177:275-83.
81. Fox SB, Turner GDH, Leek RD, Whitehouse RM, Gatter KC, Harris AL. The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat 1995;36:219-26.
82. Gasparini G, Barbareschi M, Boracchi P, et al. 67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer. Int J Cancer, 1995;60:604-10.
83. Gasparini G., Barbareschi M., Boracchi P, et al. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1995;1:131-41.
84. Goulding H, Abdul Rashid NF, Robertson J. F., et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 1995;26:1196-200.
85. Macaulay VM, Fox SB, Zhang H, et al. Breast cancer angiogenesis and tamoxifen resistance. Endocr-Rel Cancer 1995;2:97-103.
86. Miliaras D, Kamas A, Kalekou H. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathology 1995;26:165-9.
87. Obermair A, Kurz C, Czerwenka K, et al. Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer 1995;62:126-31.
88. Ogawa Y, Chung Y, Nakata B, et al. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer 1995;71:1297-301.
89. Vermeulen PB, Libura J, Libura M, et al. Re. tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:1797-8.
90. Bundred NJ, Bowcott M, Walls J, Faragher EB, Knox F. Angiogenesis in breast cancer predicts node metastases and survival. Br J Surg 1994;81:768A.
91. Conner MG, Crowe DR, Sellers MT, et al. Pathologic and molecular prognostic factors in breast carcinoma: a 16 year follow-up. Proceedings of the 1994 annual meeting of the US and Canadian Academy of Pathology. Mod Pathol 1994;7:14A.
92. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumor angiogenesis in node-negative breast carcinomas. Relationship with epidermal groth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 1994;29:109-16.
93. Fregene TA, Khanuja PS, Gimotty PA, Kellogg C, George J, Pienta KJ. The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer. Int J Oncol 1994;5:1437-45.
94. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12:454-66.
95. Obermair A, Czerwenka K, Kurz C, Kaider A, Sevelda P. Tumoral vascular density in breast tumors and their effect on recurrence-free survival. Chirurg 1994;65:611-5.
96. Sightler HE, Borowsky AD, Dupont WD, Page DL, Jensen RA. Evaluation of tumour angiogenesis as a prognostic marker in breast cancer. Proceedings of the 1994 annual meeting of the US and Canadian Academy of Pathology. Mod Pathol 1994;7:22A.
97. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144:188-94.
98. Khanuja PS, Gimotty P, Fregene T, George J, Pienta KJ. Angiogenesis quantitation as a prognostic factor for primary breast carcinoma 2 cms or less. In: Salmon SE, editor. Adjuvant Therapy of Cancer, Philadelphia: Lippincott, 1993. P. 226-32.
99. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer, 1993;55:371-4.
100. Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer 1993;29A:1141-5.
101. Visscher DW, Smilanetz S. Drozdowicz S, Wykes SM. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Am J Epidemiol 1993;15:88-92.
102. Bosari S, Lee AKC, Delellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
103. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
104. Sahin A, Sneige N, Singletary E, Ayala A. Tumor angiogenesis detected by factor-VIII immunostaining in node negative breast carcinoma: A possible predictor of distant metastasis. Lab Investig 1992;66:17A.
105. Sneige N, Singletary E, Sahin A, El-Naggar A. Multiparameter analysis of potential prognostic factors in node negative breast cancer patients. Mod Pathol 1992;5:18A.
106. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
107. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002;359:248-52.
108. Egger M. Language bias in randomised controlled trials published in English and German. Lancet 1997;350:326-9.
109. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
110. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-4.
111. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32:2474-84.
112. Vermeulen PB, Gasparini G, Fox SB, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002;38:1564-79.
113. Altman DG, Lausen B, Saurbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-35.
114. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn' t tell us. J Natl Cancer Inst 2002;94:883-93.